Navigation Links
Medarex Announces Presentations at Annual Meeting of the American Society of Clinical Oncology
Date:4/29/2008

PRINCETON, N.J., April 29 /PRNewswire-FirstCall/ -- Medarex, Inc. (Nasdaq: MEDX) announced today that the following clinical and preclinical abstracts for ipilimumab in melanoma, prostate cancer and other cancers, as well as for anti-PD-1 and anti-CD70 antibody candidates for cancer treatment, are expected to be the subject of presentations at the Annual Meeting of the American Society of Clinical Oncology, being held May 30-June 3, 2008 in Chicago:

Survival, Response, Safety and Biomarker Data of Ipilimumab in Melanoma

-- "Antitumor response and new lesions in advanced melanoma patients on

ipilimumab treatment" (Abstract #3020, Developmental Therapeutics:

Immunotherapy Session) -- Poster presentation and discussion from 2:00

p.m. to 6:00 p.m. local time on Friday, May 30, 2008.

-- "Long-term survival of patients with advanced melanoma who received

ipilimumab administered at 10mg/kg every 3 weeks for 4 doses (induction

dosing)" (Abstract #3018, Developmental Therapeutics: Immunotherapy

Session) - Poster presentation and discussion from 2:00 p.m. to 6:00

p.m. local time on Friday, May 30, 2008.

-- "Potential immune biomarkers of gastrointestinal toxicities and

efficacy in patients with advanced melanoma treated with ipilimumab

with or without prophylactic budesonide" (Abstract #3022, Developmental

Therapeutics: Immunotherapy Session) -- Poster presentation and

discussion from 2:00 p.m. to 6:00 p.m. local time on Friday, May 30,

2008.

-- "Novel efficacy criteria for antitumor activity to immunotherapy using

the example of ipilimumab, an anti-CTLA-4 monoclonal antibody"

(Abstr
'/>"/>

SOURCE Medarex, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Medarex Reports Interim Data from Ongoing Ipilimumab Combination Phase 1 Studies in Prostate Cancer at American Association for Cancer Research Meeting
2. Medarex Announces Ipilimumab Program Continues to Move Forward
3. Medarex to Receive Milestone Payment from Amgen
4. Medarex Announces Allowance of Investigational New Drug Applications for Wholly Owned Fully Human Anti-CD19 Antibody, MDX-1342
5. Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon)
6. Nuvelo Announces Positive Proof-of-Concept Data With Anticogulant NU172
7. XTENT Announces First Quarter 2008 Financial Results
8. Neuralstem Announces Issuance of Core Technology Patent in Europe
9. ROXRO PHARMA Announces Positive Clinical Proof of Concept Results for Novel Intranasal Migraine Treatment
10. PulmoBioTech Announces Details of Its Regulatory Approval Experiments
11. Lixte Biotechnology Holdings Announces That Anti-Cancer Activity Against Glioblastoma in an Animal Model Was Reported at the Annual Meeting of the American Association of Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/7/2008)...eus Laboratories Inc., a,specialty pharmaceutical ...ment of PROMETHEUS(R) IBS Diagnostic, the first an...S). The findings suggest measurable,differences in...samples,between IBS and non-IBS patients. The iden...oprietary algorithm, led to the development of PRO...
(Date:10/7/2008)... Texas Cardiac Arrhythmia,Institute (TCAI) at St. ...,only a few sites in the nation to participate in ... treat persistent atrial fibrillation. TCAI, an,in...r specializing in heart,rhythm disorders, is a par...xas Cardiovascular Consultants., "This is just an...
(Date:10/7/2008)...mmunologic Changes Induced by Glut...a Indicates Potential in Treating Inflammatory Bow... Alba Therapeutics Corporation,presented results f...,College of Gastroenterology (ACG) 2008 Annual Sci...e first Phase IIa trial conducted in celiac diseas...
(Date:10/7/2008)...-- A study published in the,scientific journal Nat...ported that InVitria,s ( http://www.InVitria.com )...n effective replacement to bovine serum albumin,in...und state of embryonic stem cell,self-renewal," di...binant,albumin in place of animal-derived serum to...
Breaking Medicine Technology:Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 2Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 3Texas Cardiac Arrhythmia Institute at St. David's Medical Center Selected to Conduct Clinical Trial for Device to Treat Atrial Fibrillation 2Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 2Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 3Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 4Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 5Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 6Diabetes doubles liver cancer risk for patients with advanced hepatitis C 20583 1Diabetes doubles liver cancer risk for patients with advanced hepatitis C 20583 2Nuvo licenses topical pain product from Paladin 20579 1Nuvo licenses topical pain product from Paladin 20579 2Nuvo licenses topical pain product from Paladin 20579 3Researchers Develop Stem Line With Sickle Cell Mutation 20576 1Researchers Develop Stem Line With Sickle Cell Mutation 20576 2Healthy Eating Bible The Word According to Gillian McKeith 20572 1Healthy Eating Bible The Word According to Gillian McKeith 20572 2Healthy Eating Bible The Word According to Gillian McKeith 20572 3
... Effective in Improving Symptoms and Urine Flow, W...Calif., May 23, 2007 /PRNewswire-FirstCall/ -- Spe... 2 safety and efficacy,data for ozarelix, the Comp...rostatic hypertrophy (BPH), at the American Urolog...onvention Center in,Anaheim, California on Tuesday...
... N.J.--(BUSINESS WIRE)--May 23, 2007 - Cytogen,Cor...tion of a,review validating the utility of its Pro...the WW domain-containing oxidoreductase,(WWOX), an...ement,in breast, prostate, lung, pancreatic, esoph...cle was published in the online,edition (25 April ...
Other Medicine Technology:Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at,Annual Meeting of American Urological Association 2Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at,Annual Meeting of American Urological Association 3Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at,Annual Meeting of American Urological Association 4Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at,Annual Meeting of American Urological Association 5Cytogen Reports Publication Validating the Utility of its,Proprietary ProChart Database 2Cytogen Reports Publication Validating the Utility of its,Proprietary ProChart Database 3Cytogen Reports Publication Validating the Utility of its,Proprietary ProChart Database 4
(Date:10/8/2008)... a leader in the commercial two-way radio industry...is new technology allows users to talk via two way...or even thousands of miles away! , ...-- Fast Radios, a leader in the commercial two-way...com/roip.html [2-way radios over internet (RoIP) _...
(Date:10/7/2008)...EMD in North America) announced today the extensio...ra, Inc., a leading nanotechnology co-development ...rmany (Business Wire EON) October 7, 2008 -- The ...d in February 2007, was to develop innovative, nan...Merck,s materials. , , , After successfully meetin...
(Date:10/7/2008)...-USNewswire/ -- The Ohio Nurses,Association Politi...its,final round of endorsed candidates for the Nov... SD 26 Karen Gillmor (R) Tiffin, Ohio House of R...City;, HD 28 Connie Pillich (D) Cincinnati;, HD ...endorsed candidates for the Ohio General Assembly ...
(Date:10/7/2008)...s easier to spot , , TUESDAY, Oct. 7 (He...e type of breast cancer in women with an evaluated...make an earlier diagnosis of another form of breas...viously had been shown to reduce the risk of estro...at high risk of the disease, but not to affect the...
Breaking Medicine News(10 mins):Health News:Fast Radios Introduces RoIP: Extending Two-Way Radio Range Thousands of Miles 2Health News: Merck KGaA and Nano-Terra Announce Extension of Nanotechnology Solutions Alliance 2Health News: Merck KGaA and Nano-Terra Announce Extension of Nanotechnology Solutions Alliance 3Health News:ONA-PCE Announces Final Round of Endorsed Candidates for Ohio General Assembly 2Health News:ONA-PCE Announces Final Round of Endorsed Candidates for Ohio General Assembly 3Health News:Tamoxifen Speeds Diagnosis of ER-Negative Breast Cancer 2
...sity of NSW researchers in Australia are conductin...study could answer some questions about aging. // ...ere are vast differences between them,' study lead...'By studying twins, we will be able to better dete...
...and vegetable juices may have the unique property ...ding to a new study. //US researchers examined mor... the latest issue of the American Journal of Medic...isk of Alzheimer's was reduced by as much as 76 pe...
...s conducted by a researcher from the Institute of ...that human body// is designed to strongly resist a...o prevent weight gain. The findings of the study w...rnational gathering of obesity experts hosted by Q...
...-based Center for Disease Control and Prevention (...elbourne-based pharmaceutical development company/...ndidate vaccine developed by BioDiem and its Dutch...in Atlanta, the US government's leading site for r...
Other Medicine News:Health News:Human Body Designed To Resist Weight Loss 2
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
Medicine Products: